Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Intercept (ICPT): In this Case, the Black Box Warning is a Positive - BairdFebruary 1, 2018 10:13 AM Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced CirrhosisFebruary 1, 2018 9:46 AM RBC Capital on Intercept Pharma (ICPT): Benign Label Update Removes Key Overhang, Should Set Stage for Ocaliva GrowthFebruary 1, 2018 9:42 AM FDA Adds Boxed Warning for Correct Dosing of Intercept Pharma's (ICPT) OcalivaFebruary 1, 2018 9:05 AM